Alaunos Therapeutics, Inc. (TCRT)

Alaunos Therapeutics Revenue

In the year 2023, Alaunos Therapeutics had annual revenue of $5.00K, a decrease of -99.83%. Revenue in the quarter ending December 31, 2023 was $1,000.00, a -90.91% decrease year-over-year.

• Revenue (ttm): $5.00K
• Revenue Growth: -99.83%
• P/S Ratio: 4,227.30
• Revenue / Employee: $5,000
• Employees: 1
• Market Cap: 21.14M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.00K	-2.92M	-99.83%
Dec 31, 2022	2.92M	2.52M	634.17%
Dec 31, 2021	398.00K	-	-
Dec 31, 2020	0	-	-
Dec 31, 2019	0	-	-
Dec 31, 2018	146.00K	-6.24M	-97.71%
Dec 31, 2017	6.39M	-472.00K	-6.88%
Dec 31, 2016	6.86M	2.53M	58.38%
Dec 31, 2015	4.33M	2.96M	215.51%
Dec 31, 2014	1.37M	573.00K	71.63%
Dec 31, 2013	800.00K	-	-
Dec 31, 2012	800.00K	133.00K	19.94%
Dec 31, 2011	667.00K	-	-
Dec 31, 2010	0	-	-
Dec 31, 2009	0	-	-
Dec 31, 2008	0	-	-
Dec 31, 2007	0	-	-
Dec 31, 2006	0	-	-
Dec 31, 2005	0	-	-
Dec 31, 2004	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.